Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007

Clinical Microbiology and Infection

Volumn 16, Issue 5, 2010, Pages 472-476

  Mata, C ^a,b   Miro E ^a   Rivera, A ^b   Mirelis, B ^a   Coll, P ^a,b   Navarro, F ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

AmpC lactamases; Antimicrobial resistance mechanism; Epidemiology of resistance

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE ACC 1; BETA LACTAMASE AMPC; BETA LACTAMASE CMY 25; BETA LACTAMASE CMY 27; BETA LACTAMASE CMY 4; BETA LACTAMASE DHA 1; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMPLICON; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CHROMOSOME DELETION; CONTROLLED STUDY; ENTEROBACTERIACEAE; GENETIC ANALYSIS; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; SALMONELLA ENTERICA; SPAIN;

ENTEROBACTERIACEAE; PROTEUS MIRABILIS;

EID: 77952934404     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02864.x     Document Type: Note

References (17)

1. Philippon A, Arlet G, Jacoby A. Plasmid-determined AmpC-Type β-lactamases. Antimicrob Agents Chemother 2002, 46:1-11.
2. Pérez-Pérez FJH, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
3. Blanc V, Mesa R, Saco M. ESBL- and plasmidic class C β-lactamase-producing E. coli strains isolated from poultry, pig and rabbit farms. Vet Microbiol 2006, 118:299-304.
4. Hopkins KL, Batchelor MJ, Liebana E, Deheer-Graham AP, Threlfal EJ. Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales. Int J Antimicrob Agents 2006, 28:180-192.
5. Song W, Kim JS, Kim HS. Increasing trend in the prevalence of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn Microbiol Infect Dis 2006, 55:219-224.
6. Pitout JD, Gregson DB, Church DL, Laupland KB. Population-based laboratory surveillance for AmpC β-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 2007, 13:443-448.
7. Navarro F, Pérez-Trallero E, Marimón JM, Aliaga R, Gomariz M, Mirelis B. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J Antimicrob Chemother 2001, 48:383-389.
8. Performance standards for antimicrobial susceptibility testing: Seventeenth Informational (suppl) M100-S17 2007, Clinical and Laboratory Standards Institute (CLSI), PA, USA, CLSI, Wayne
9. Aragón LM, Mirelis B, Miró E. Increase in β-lactam-resistant Proteus mirabilis strains due to CTX-M and CMY-type as well as new VEB- and inhibitor-resistant TEM-type β-lactamases. J Antimicrob Chemother 2008, 61:1029-1032.
10. Mirelis B, Rivera A, Miró E, Mesa RJ, Navarro F, Coll P. A simple phenotypic method for differentiation between acquired and chromosomal AmpC β-lactamases in Escherichia coli. Enferm Infecc Microbiol Clin 2006, 24:370-372.
11. Empel J, Baraniak A, Literacka E. Molecular survey of β-lactamases conferring resistance to newer β-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother 2008, 52:2449-2454. the Beta-PL Study Group
12. Adler H, Fenner L, Walter P. Plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: prevalence at a Swiss university hospital and occurrence of the different molecular types in Switzerland. J Antimicrob Chemother 2008, 61:457-458.
13. Álvarez M, Tran JH, Chow N, Jacoby GA. Epidemiology of conjugative plasmid-mediated AmpC β-lactamase in the United States. Antimicrob Agents Chemother 2004, 42:533-537.
14. Woodford N, Reddy S, Fagan EJ. Wide geographic spread of diverse acquired AmpC β-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J Antimicrob Chemother 2007, 59:102-105.
15. Yen Tan T, Yong LS, He J, Hsien T, Yang L. Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Antimicrob Agents Chemother 2009, 53:146-149.
16. Hanson ND. AmpC β-lactamases: what do we need to know for the future? J Antimicrob Chemother 2003, 52:2-4.
17. Conejo MC, Mata C, Navarro F, Pascual A. Detection and reporting betalactam resistance phenotypes in Escherichia coli and Klebsiella pneumoniae: a multicentre proficiency study in Spain. Diagn Microbiol Infect Dis 2008, 62:317-325. the GEMARA collaborative group